Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Nimblify Opens Platform to Build and Exchange Standards-Based Protocol Calendars to Sponsors
  • USA - English


News provided by

Nimblify, Inc.

Apr 28, 2016, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Madison, Wis. (PRWEB) April 28, 2016 -- Today Nimblify, Inc., a clinical trials technology company, announced its latest offering, the Protocol Calendar Exchange, is officially open to all sponsors in the industry. The platform includes a robust repository of pre-built, pre-reviewed protocol calendars available for sites to download into their clinical trial management system (CTMS), which is the site’s preferred tool to drive day-to-day operations across all their trials. Each calendar is a structured representation of a protocol’s schedule of events in a standard format that carefully reflects the sponsor’s intent. These centrally built calendars can be shared and reused by multiple sites on the same protocol. This consistency across sites improves the quality and safety of study conduct, minimizing deviations. Since its inception, Nimblify has built more than 2,500 unique protocol calendars as part of an ever-expanding library. Following early success working with a variety of sponsors, now any sponsor has the ability to directly build and review their protocols in the platform before making them available to their sites through the exchange. This standards-based approach benefits sponsors in unprecedented ways and helps solve a critical issue.

The need for standardization

For every protocol, a sponsor sends each participating site a large file of the protocol document. This file often includes unstructured representations of the schedule of events and procedures, instructions buried in the footnotes and modifications reflected elsewhere in the protocol document. Each site creates the protocol calendar from scratch using the sponsor’s document, leaving calendar builders at every site to interpret the protocol in his or her own unique way. Based on the size of the trial and the number of participating sites, this reinterpretation can happen from ten to a hundred times. Hence, the amount of variation across the protocol quickly escalates. The lack of consistency across sites can lead to subsequent deviations and violations during the participant lifecycle on the trial. Such deviations from the calendar can result in missed visits and inaccurate treatments, creating non-trivial safety concerns for participants and regulatory compliance challenges for the site and sponsor.

Creating a source of truth that provides downstream benefits

The Protocol Calendar Exchange ensures a protocol calendar is built once and can be used many times by all participating sites. This not only eliminates the need for each site to replicate build efforts, but it also guarantees the schedule of patient visits, tests and procedures is consistent and accurate across sites. Having a standard calendar available up-front reduces startup times while helping sites with tasks such as forecasting participant visits, budgeting, coverage analysis, invoicing, payment reconciliation and more. Spending less time on all of these activities ultimately allows treatments to get to market faster while reducing the overall cost of clinical trials.

The Protocol Calendar Exchange was developed and guidelines were established in collaboration with a variety of research organizations. Nimblify worked with Washington University School of Medicine for a period of nine months to build out over 600 study calendars. Dave Mulvihill, IT Project Manager, commented, “Providing clear guidelines for how details from protocol documents would be extracted, interpreted and applied toward the creation of calendars allowed us to enjoy extremely fast turnaround times. As such, local study teams’ review cycles were expedited which ultimately led to shortened activation timelines.”

Nimblify has developed a dedicated group to lead this initiative made up of experienced study coordinators and CRAs. “The Calendar Team is very good at picking up visits in complicated cancer studies where visits are not in one straight flow,” said Magdalene Lindenbaum, Project Manager, Clinical Trials Administration Office, UCLA. Nimblify was able to build out a robust calendar library by working side-by-side with its customers. “Working with the Calendar Team always felt like a collaborative effort and never like a vendor just providing services,” added Mulvihill.

Initial success with sponsors

Nimblify began working directly with sponsors – ranging from national cooperative groups to major pharmaceutical companies – to include their protocols in the exchange. Nimblify built the sponsor’s protocol calendars, which were then reviewed and approved by each sponsor and made available to sites participating on the trial. After verifying a site was on a trial, Nimblify gave each site access to import the protocol calendar into the site’s pre-integrated CTMS environment or provided it in spreadsheet format. The sponsors expedited trial activation timelines while sites decreased the amount of time spent on protocol interpretation and calendar building. After these successful pilots, Nimblify officially made the Protocol Calendar Exchange available to benefit more sponsors in the industry. Nimblify continues to offer the option of building protocol calendars for sponsors.

“Sponsors now have the ability to standardize and share protocol calendars across sites participating on the same study, which supports protocol compliance, quality, patient safety and overall consistencies,” said Nimblify Founder & CEO, Shree Kalluri. As more sites use the same calendar, room for error throughout the trial decreases. “The greatest impact on the quality of conduct across sites will be seen when research organizations conform to standards. By building the calendar once and reusing it many times, we gain industry-wide efficiencies,” added Kalluri.

Most sites carry out the protocol’s activities using the calendar they build in their site-owned CTMS, as it’s the site’s primary and preferred tool. Sponsors can leverage technology already used by research sites, including those using OnCore® Enterprise Research and Allegro® CTMS offered by Forte Research Systems. Other technology vendors will be offered APIs to interface with the exchange or can use an Excel-based version of the protocol calendar.

Sponsors can contact Nimblify to get involved with the Protocol Calendar Exchange by emailing info(at)nimblify(dot)com or filling out this form. For more information, visit: http://nimblify.com/calendars.

About Nimblify, Inc.
Nimblify, Inc. is a clinical trials technology company dedicated to creating industry-wide efficiencies by connecting stakeholders in clinical research. Nimblify created Participant Payments, a patient-centric payment system, and hosts Research Resonance Network, an award-winning benchmarking tool that uses a standard set of operational metrics and is free for sites. Nimblify also hosts the Protocol Calendar Exchange, a robust repository of pre-built, pre-reviewed protocol calendars available for clinical trial management systems. Spun out of Forte Research Systems in August 2015, Nimblify is a privately held company and is headquartered in Madison, Wis. For more information, please visit http://nimblify.com/.

Kristina Lopienski, Nimblify, Inc., http://nimblify.com/, +1 6088267818, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.